Roche Veteran Launches Biotech Aiming To Disrupt Eye Drug Market

EyeBio Raises $65m In Series A

 
• By Andrew McConaghie
  
Retinography
Alamy • Source: An aging population means demand for retinal disease therapies will continue to climb.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip